Protein receptor-independent plasma membrane remodeling by HAMLET: a tumoricidal protein-lipid complex

Area of Science:

• Cell Biology
• Biochemistry
• Cancer Research

Background:

• Traditional signal transduction relies on extracellular ligands activating cell surface receptors.
• Emerging evidence highlights the role of specialized membrane domains in cellular signaling.
• The protein-centric view of signal transduction is being challenged by alternative mechanisms.

Purpose of the Study:

• To investigate membrane perturbation as a mechanism for activating cell death in cancer cells.
• To explore the role of Human Alpha-lactalbumin Made LEthal to Tumor cells (HAMLET) in cancer therapy.
• To understand the receptor-independent action of HAMLET on tumor cell membranes.

Main Methods:

• Utilized model membranes to observe HAMLET-induced transformations of vesicular motifs.
• Analyzed tumor cell membranes for gross remodeling in response to HAMLET.
• Investigated HAMLET accumulation within de novo membrane conformations, specifically membrane blebs.
• Identified direct interactions between HAMLET and target proteins like Ras GTPases.
• Assessed the sensitivity of healthy cell membranes to HAMLET.

Main Results:

• HAMLET induces receptor-independent transformation of membrane structures, remodeling tumor cell membranes.
• HAMLET accumulates in de novo membrane conformations (blebs), facilitating interactions with target proteins.
• HAMLET demonstrates selective toxicity, with healthy cell membranes showing lower sensitivity.
• HAMLET-induced membrane curvature-dependent conformations act as surrogate receptors.

Conclusions:

• Membrane perturbation by HAMLET activates a conserved cell-death program in cancer cells.
• HAMLET's mechanism bypasses traditional receptor-mediated signaling, offering a novel therapeutic strategy.
• HAMLET-induced membrane conformations serve as critical platforms for initiating signal transduction leading to cancer cell death.